AddedRisk Factors
will be resolved without additional inquiry, corrective actions, or enforcement measures that could adversely affect our business.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedRisk Factors
Our CROSSBOW counter‑UAS activities are subject to complex, rapidly evolving, and stringent U.S. regulatory, export control, aviation, and procurement requirements, and changes in these regimes or our failure to comply with them could adversely affect our ability to develop, test, demonstrate, sell, or deploy these systems.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedRisk Factors
In the United States, counter‑UAS systems operate within a highly regulated and rapidly evolving legal environment. The federal statutory and regulatory framework governing the development, use, sale and operation of counter‑UAS technologies continues to develop at a significant pace and is subject to change. We cannot predict the impact of future legal, regulatory, or policy changes by U.S. governmental entities relating to counter‑UAS technologies. New or amended laws, regulations, or policies could increase our compliance costs or restrict market opportunities for the testing, demonstration, sale, or use of counter‑UAS systems, including our CROSSBOW system. Our activities relating to CROSSBOW are also subject to stringent export control and government procurement requirements, including ITAR, EAR, and other domestic and international restrictions governing the classification, transfer, sale, end‑use, and end‑users of defense‑related technologies. Changes in these regulations, delays or difficulties in obtaining or maintaining required licenses or approvals, or adverse jurisdiction, classification, or end‑user determinations could restrict our ability to sell, deploy, or service CROSSBOW systems, particularly outside the United States. The development, testing and use of certain counter‑UAS laser systems in the United States may fall under the regulatory oversight of the Federal Aviation Administration (“FAA”) or other government agencies, depending on factors such as the operating environment and the nature of the customer. Although many of our potential U.S. government and defense customers operate pursuant to military or other federal authorizations outside the FAA’s civil regulatory framework, certain testing or demonstration activities may still require coordination with, or authorization from, the FAA and other agencies. Changes in applicable FAA or other governmental policies or requirements, or the inability to obtain or comply with any authorizations that may be required for particular testing or demonstration scenarios, or for the sale or deployment of CROSSBOW, could delay, limit, or prevent our ability to conduct such activities. Any of the foregoing regulatory developments, enforcement actions, or compliance challenges could restrict our ability to advance the CROSSBOW product line and limit its potential future contribution to our business.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedRisk Factors
interests could delay, prevent or cause a change in control of the Company and might affect the market price of our common stock.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RemovedRisk Factors
•successfully develop new product lines, such as the handheld welder, UV, visible and ultrafast fiber lasers with competitive features that extend our product line;
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
We have a high fixed cost base due to our vertically integrated business model. Approximately 75% of our approximately 4,740 employees as of December 31, 2024 were employed in our manufacturing operations. We may not adjust these fixed costs quickly enough or sufficiently to adapt to rapidly changing market conditions. Our gross profit, in absolute dollars and as
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
We now make fiber laser systems and accessories targeted at specific medical applications. In addition, we sell our commercial fiber and diode laser modules, subassemblies and systems to OEMs that incorporate them into their medical products. With respect to such products, some of our manufacturing facilities, and the manufacturing facilities of any of our third-party component manufacturers or critical suppliers, are required to comply with the FDA’s Quality System Regulation and those of other countries (“QSR”), which sets forth minimum standards for the procedures, execution and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage, and shipping of the
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedRisk Factors
We are subject to risks of doing business in Belarus, which historically provided mechanical parts to our German subsidiary and former Russian subsidiary and which does not currently provide parts to our affiliates outside of Belarus. We are also subject to risks of doing business in China, as approximately 25% of our sales in 2024 were to Chinese customers. The results of our operations, business prospects and facilities in China and Belarus are subject to the economic and political
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RewordedRisk Factors
Additionally, such actions could result in significant costs associated with loss of our intellectual property, impairment of our ability to conduct our operations, rebuilding our network and systems, prosecuting and defending litigation, responding to regulatory inquiries or actions, paying damages or taking other remedial steps.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we or our third-party vendors fail to comply with FDA regulations or similar legal requirements in foreign jurisdictions relating to the manufacturing, labeling design, manufacture, labeling, marketing, distribution or marketing post-market surveillance of our products or any component part, we may be subject to fines, injunctions and penalties, injunctions, product recalls, penalties or other enforcement actions, and our ability to commercially distribute and sell our products may be negatively impacted.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
These include public and private companies such as Coherent, Inc., Laserline GmbH, Lumentum Holdings Inc., Maxphotonics Co., Ltd., MKS Instruments, Inc., nLight, Inc., Trumpf GmbH + JPT Opto-Electronics Co.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
We incurred a foreign exchange loss of $9.4 million in 2025 and a loss of $5.5 million in 2024 and a gain of $1.4 million in 2023. 2024.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
See Note 3, "Fair Value Measurements" in the Notes to Consolidated Financial Statements in Part IV, Annual Report for further information about our cash equivalents equivalents, short-term investments and short-term long-term investments.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, the new U.S. presidential administration has articulated implemented new tariff policies that it may impose substantial new or substantially increased tariffs on foreign imports into the U.S.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
If the ASPs of our products decline further and we are unable to increase our unit volumes, introduce new or enhanced products with higher margins or reduce manufacturing costs to offset anticipated decreases in the prices of our existing products, our operating results may be adversely affected.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
Although we have implemented compliance measures designed to prevent transactions prohibited by current or future Trade Controls, we have previously identified, and may continue to identify, instances in which we exported products without obtaining the required export authorizations and/or submitting the required requests.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
Several laws similar to the CCPA have been approved in the United States at the state level and more are being proposed at the federal and state levels.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
These developments could adversely affect our ability to compete for customers and increase our revenues. revenues, or could decrease our revenues or profits or increase our costs.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
A significant portion of our sales are to customers in China, which accounted for 25%, 29%, 25% and 28% and 34% of net sales in 2024, 2023 2025, 2024 and 2022, 2023, respectively.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedRisk Factors
These include public and private companies such as Coherent, Inc., Ltd., Laserline GmbH, Lumentum Holdings Inc., Maxphotonics Co., Ltd., MKS Instruments, Inc., nLight, Inc., Trumpf GmbH + Co.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
Recently announced U.S. Government Tariffs. We continue to closely monitor changes in international trade relations and economic and monetary policies, including recently announced tariffs on imports into the U.S. from China, Germany and other countries, as well as retaliatory tariffs in affected countries, which could adversely impact the global economy and our operating results. On February 20, 2026, the U.S. Supreme Court rendered a decision invalidating tariffs imposed under the International Emergency Economic Powers Act. This decision introduces uncertainty regarding potential refund processes and future trade policy actions. We continue to monitor developments around the Supreme Court’s decision and evaluate its potential impact on our future financial results and business. The Supreme Court's ruling has no direct impact on the tariffs in place under Section 232, including tariffs on steel and aluminum. The impact to gross margin related to higher tariffs for the year ended December 31, 2025 was approximately 120 basis points, respectively, as compared to the year ended December 31, 2024.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
•Tariffs and counter-tariffs added, increased, reduced or eliminated in any period;
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
On January 5, 2026, the OECD released a comprehensive package introducing a “side-by-side arrangement” in relation to Pillar Two. Importantly, once implemented, this guidance is intended to prevent other jurisdictions from imposing tax on the U.S. profits of American companies. We will continue to monitor U.S. and international legislative developments, including additional guidance related to the Side-by-Side package, in order to evaluate any potential impact on our operations
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
On July 4, 2025, the U.S. enacted H.R. 1 "A bill to provide for reconciliation pursuant to Title II of H. Con. Res. 14", commonly referred to as the One Big Beautiful Bill Act ("OBBBA"). OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the 2017 Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. Changes in tax laws may affect recorded deferred tax assets and deferred tax liabilities and our effective tax rate in the future. The legislation does not have a material impact on our financial statements.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
(2)Revenue in Europe declined year over year primarily due to lower sales in cutting and welding applications and the impact of the divestiture of our Russian operations, partially offset by increased sales in cleaning applications, driven largely by the cleanLASER acquisition, as well as increased sales in additive manufacturing.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
Materials processing sales accounted for 85.7% of total revenue and increased 0.3% year over year, as a result of increased sales in cleaning, mainly due to the cleanLASER acquisition, additive manufacturing, micromachining, drilling, and annealing, partially offset by decreased sales in cutting, service and parts, and other material processing applications. Other applications sales increased 19.9% year over year driven by higher revenue in advanced applications and medical procedures.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
(5) The facility does not have a stated maturity date. The interest rate in effect as of December 31, 2025 is fixed through September 2026. After that date, the interest rate may be renegotiated and availability may be terminated in accordance with the terms of the facility.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
In addition to the financial covenants, the credit facility includes additional customary events of default, including non-payment of principal, interest or fees, violation of covenants, cross default to certain other indebtedness, invalidity of any loan document, material judgments, bankruptcy and insolvency events and change of control, subject, in certain instances, to cure periods. Upon the occurrence of an event of default, the lenders may elect to declare amounts outstanding under the Credit Agreement immediately due and payable.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
The financial covenants in our loan documents may cause us to not make or to delay investments and actions that we might otherwise undertake because of limits on capital expenditures and amounts that we can borrow or lease. In the event that we do not comply with any one of these covenants, we would be in default under the loan agreement or loan agreements, which may result in acceleration of the debt, cross-defaults on other debt or a reduction in available liquidity, any of which could harm our results of operations and financial condition.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
•an increase in cash used by inventory as we manufactured more in 2025 compared to 2024 when we reduced our investments in inventory;
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
AddedMD&A
•an increase in cash provided by accrued expenses and other current liabilities due to timing of payments for accrued personnel costs, increase in cash provided by customer deposits, and an increase in billings in excess of cost and estimated earnings on customized systems under contract, partially offset by an increase in lease payments and other activities; and
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RemovedMD&A
Sale of our Russian Operations. On August 29, 2024, we completed the sale of our Russian subsidiary, Scientific and Technical Association “IRE-Polus”, pursuant to a share purchase agreement with a purchaser entity associated with Softline
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
Supply Chain. We experienced supply chain issues related to the Covid epidemic and related to sanctions that affected the flow of goods to and from our factories in Russia and Belarus. These issues caused us to maintain higher levels of inventory in order to minimize the risk of disruption in production. While these supply chain issues are no longer having a significant impact on our operations, we have experienced increases in our provisions for excess and obsolete inventory as a result of higher inventory levels. In 2024, we recorded additional inventory provisions of $29.5 million attributed to items previously considered safety stock and items that became technologically obsolete.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
result of the review of the inventory in Russia. For the rest of our operations, as safety stock increased excess and obsolete inventory reserves increased during 2022.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
Sales for materials processing applications decreased primarily due to lower sales of high power CW lasers, pulsed lasers, and other laser products and services.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•High power CW laser sales decreased due to lower sales for cutting and welding applications, and were primarily impacted by softer industrial demand and a decrease in e-mobility investments. Pulsed laser sales decreased due to lower demand in foil cutting and micro-machining applications.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
Sales from other applications decreased primarily due to decreased demand for lasers used in medical procedures.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
8.4% of sales, for the year ended December 31, 2024, as compared to $45.5 million, or 3.5% of sales, for the year ended December 31, 2023.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
(3) At December 31, 2024, there were no drawings. This facility renews annually.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•a decrease in cash provided by net income after adjusting for non-cash operating activities, mainly due to lower sales; and
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•an increase in cash provided by inventory as supply chain disruptions moderated requiring less investment in safety stock and due to a targeted plan to reduce inventory levels;
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
•a decrease in cash used by accrued expenses from lower payouts related to accrued compensation and bonuses.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RemovedMD&A
In 2025, we expect to incur approximately $105.0 million to $115.0 million in capital expenditures. Capital expenditures include investments in property, facilities and equipment to replace capacity in Russia or increase redundant capacity for critical components and upgrade or replace equipment at other facilities that is beyond its useful life. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period. We intend to finance our capital expenditures with existing cash, cash equivalents and short term investments as well as with cash generated from operations.
Read it in 10-K Feb 20, 2025 at sec.govopen_in_new
RewordedMD&A
Funded debt The net leverage covenant requires we maintain a trailing twelve-month ratio, which is decreased by our the sum of all indebtedness for borrowed money on a consolidated basis, less cash and available marketable securities not classified as long-term investments in the U.S. in excess of $50 million up to a maximum of $500 million. million, to consolidated EBITDA that is less than 3.0 times.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
The impairment of long-lived assets in 2024 was primarily related to During the during the year ended December 31, 2024, we completed an impairment analysis of the assets located in Belarus of $26.6 million as a result of new EU sanctions that will limit limited our ability to supply laser cabinets and other mechanical components from our factory in Belarus. that facility.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Expenses related to provisions for excess or obsolete inventory and other valuation adjustments increased decreased by $37.0 $52.4 million to $30.1 million, or 3.0% of sales, for the year ended December 31, 2025, as compared to $82.5 million, or 8.4% of sales, for the year ended December 31, 2024.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
This change was primarily a result of an increase of $3.5 $5.8 million in personnel and related costs and $2.3 million in premises expense, partially offset by $2.2 million in lower depreciation and amortization expense. costs, reflecting higher performance-based compensation associated with improved financials results.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
As we continue to expand globally, there is a risk that, due to complexity within and diversity among the various jurisdictions in which we do business, a governmental agency may disagree with the manner in which we have computed our taxes.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Provision for income taxes was $14.0 million in 2025 compared to $19.6 million in 2024 compared to $56.0 million in 2023, 2024, representing an effective tax rate of 31.0% in 2025 and (12.1)% in 2024 and 20.4% in 2023. 2024.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
At December 31, 2024, 2025, there was $1.1 million drawn on these lines; and there were no amounts drawn on this line, however, there were $2.1 $1.8 million of guarantees issued against the line lines which reduces total availability.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
The following table presents our principal sources of liquidity:As of December 31, 2025 2024 2023 (In thousands) Cash and cash equivalents $ 403,790 $ 620,040 $ 514,674 Short-term investments 435,538 310,152 662,807 Unused credit lines and overdraft facilities 224,432 78,115 78,506 Working capital (excluding (defined as current assets, excluding cash and cash equivalents and short-term investments) investments, minus current liabilities) 350,075 295,784 522,312
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Net loss attributable to IPG Photonics Corporation income (loss) as a percentage of our net sales decreased increased by 35.6% 21.6% to (18.6)% 3.1% in 2025 from (18.5)% in 2024 from 17.0% in 2023 due to the factors described above.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Gross margin decreased mainly due to increased provisions for excess and obsolete inventory, specifically The prior year costs of sales included additional inventory provisions of $29.5 million attributed to items previously considered safety stock and items that became technologically obsolete.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash provided by operating activities decreased by $48.1 $172.6 million to $75.3 million in 2025 from $247.9 million in 2024 from $296.0 million in 2023 primarily due to a decrease in net income after adding back non-cash expenses, partially offset by expenses and an increase in cash provided used by working capital.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
RewordedMD&A
Net sales decreased increased by $310.3 $26.7 million, or 24.1%, 2.7%, to $1,003.8 million in 2025 from $977.1 million in 2024 from $1,287.4 million in 2023. 2024.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new
Quiet changesMD&A
Gross margins generally decline if production volumes are lower as a result of a decrease in sales or a reduction in inventory because the absorption of fixed manufacturing costs will would be reduced.
Read it in 10-K Feb 23, 2026 at sec.govopen_in_new